-Float = 6.5M
-Dec 17 2020: Announces FDA Approval of IND Application for its Brain Cancer Drug Candidate Berubicin
-SPY pattern: Bowl
-Intraday pattern: Gap & Crap
-Other notes: N/a
Strategy: B grade Distribution of 2.96 floor
Confluence: N/a
Strike Zone: N/a
Sizing (lots + emergency): 1000
Risk (stop / Rs): 1.98 reclaim
Was a worthy attempt but 1.98 was the obvious cut spot for me since it was previous micro floor on the stall and there was a clear seller there after it broke, so cut for total -0.5R loss when it reclaimed.
Execution detail:
Date/time | Symbol | Side | Price | Position |
---|---|---|---|---|
2020-12-18 11:00:22 | CNSP | sell | $2.961 | short |
2020-12-18 11:16:20 | CNSP | buy | $2.990 | 0 |
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!